Skip to main content

Join Echosens, Booth #305 at  the NVSBE!

The Gaylord Opryland Resort & Convention Center

Nashville, TN

December 10 – 11, 2019

To learn more about NAFLD and the VA, download our white paper “Aligning with the Veterans Administration to Battle Chronic Liver Disease.”

Echosens will provide a live demonstration of a FibroScan examination, in partnership with Fidelis, at the Department of Veterans Affairs’ (VA) National Veterans Small Business Engagement. The VA now includes in its contract with Echosens the FibroScan mini+ portable technology as part of its strategy to improve access to non-invasive liver assessment and early detection of asymptomatic non-alcoholic fatty liver disease (NAFLD).

The FibroScan examination is a simple, non-invasive test that provides scores that can be used to diagnose and monitor liver health, providing immediate results for the treating clinician. The addition of portable FibroScan systems will enable the VA to reach deeper into the community, saving time, money and, most importantly, reducing the healthcare burden on our veterans.

FibroScan served as a valuable tool in the VA's successful efforts of nearly 100 percent hepatitis C eradication within the VA. As part of an overall assessment, FibroScan can help detect liver disease before it progresses and becomes symptomatic, reducing costs and improving outcomes.

Dustin LeeOwner and President, Fidelis Sustainability, LLC, USMC Scout Sniper Veteran and Principal
Learn more about FibroScan technology